Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150
CANO.WS
CANO.WS was delisted on the 9th of November, 2023.
28 hedge funds and large institutions have $80.5M invested in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 in 2021 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 11 closing their positions.
82% more capital invested
Capital invested by funds: $44.3M → $80.5M (+$36.2M)
20% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 5
20% less funds holding
Funds holding: 35 → 28 (-7)
64% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LP
LMR Partners
London,
United Kingdom
|
+$8.91M |
| 2 |
Walleye Capital
New York
|
+$2.26M |
| 3 |
ICM
Ionic Capital Management
New York
|
+$1.7M |
| 4 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
+$1.65M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.57M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCM
LH Capital Markets
New York
|
-$4.7M |
| 2 |
AC
Athanor Capital
New York
|
-$1.45M |
| 3 |
GL
Governors Lane
New York
|
-$923K |
| 4 |
MCM
Moore Capital Management
New York
|
-$904K |
| 5 |
CAC
Cowen and Company
New York
|
-$622K |
CANO.WS Hedge Fund Activity: Q3 2021 in Review
28 of the 5,729 institutional investors tracked by Wall St. Rank reported a position in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) for Q3 2021, worth a combined $80.5M — up 82% from $44.3M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of CANO.WS and 4 opened new positions — a net loss of 7 holders — while 5 trimmed existing stakes and 6 added.
The largest buyer was LMR Partners, opening a new position worth an estimated $8.91M. The largest seller was LH Capital Markets, exiting entirely with an estimated $4.7M sold.
- 28 institutional investors held Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) as of Q3 2021, down from 35 in Q2 2021.
- Funds reported $80.5M of Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 stock for Q3 2021, up 82% quarter-over-quarter.
- 4 funds opened new Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 positions in Q3 2021 and 11 closed out, a net change of -7 holders.
- The largest Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 buyer in Q3 2021 was LMR Partners, an estimated $8.91M added.
- The largest Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 seller in Q3 2021 was LH Capital Markets, an estimated $4.7M sold.
Based on aggregated 13F filings for Q3 2021.